News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 73–108
- Matches
- 1063
- Sources here
- 21
- Companies here
- 18
Active search
1063 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Inhibrx Biosciences (NASDAQ:INBX) Posts Quarterly Earnings Results, Misses Expectations By $0.06 EPS
Inhibrx Biosciences (NASDAQ:INBX) reported a quarterly loss of $2.34 per share, missing analysts' consensus estimates by $0.06. Following the announcement, the stock fell 1.4% to $97.01. Despite mixed analyst sentiment resulting in a "Hold" rating, institutional investors hold a significant 82.46% of the company's …
SBS Stock Slides As Momentum Traders Eye Key Support
Companhia de Saneamento Básico do Estado de São Paulo – Sabesp (SBS) stock has fallen over 7% due to privatization uncertainty, breaking a multi-week uptrend. While SBS is a large, utility-style company with steady revenues and a stable profit margin, its recent price action …
Form 8K Inhibrx Biosciences Inc For: 13 August By Investing.com
This article reports on the filing of a Form 8K by Inhibrx Biosciences Inc. for August 13. The brief notice highlights the company's regulatory submission without providing further details on its content. It includes the stock symbol INBX, which saw a slight decrease.
Inhibrx Biosciences (INBX) deepens losses but reports pivotal ozekibart and INBRX-106 data
Inhibrx Biosciences (INBX) reported a net loss of $70.1 million for the first half of 2026, with no revenue, while holding $133.3 million in cash and equivalents. Despite the losses, the company advanced its clinical pipeline, with ozekibart achieving a statistically significant progression-free survival …
FDA Sets April 2027 Goal Date for Inhibrx's Ozekibart
Inhibrx reported a net loss of $36.7 million in Q2 2026, with R&D expenses at $23.9 million and G&A at $8.3 million. The company secured an amended loan with Oxford Finance for up to $325.0 million, with $100.0 million already funded. The FDA accepted …
Enhanced Group, Inc. Reports Second Quarter 2026 Results
Enhanced Group, Inc. announced its Q2 2026 financial results, reporting $17.7 million in revenue, primarily from sponsorships for the inaugural Enhanced Games, but also a net loss of $61.9 million due to significant investment in the event and public company operations. The company highlighted …
Lionheart Holdings (NYSE: CUB) sees 6.52% stake reported by Decagon Asset Management
Decagon Asset Management LLP and Benjamin John Durham have reported a beneficial ownership of 1,500,000 Class A ordinary shares in Lionheart Holdings (NYSE: CUB), which constitutes a 6.52% stake in the company. Both parties maintain sole voting and dispositive power over these shares, with …
Robinhood Raises $225.5 Million to Put Retail Money Into Startups
This article first appeared on GuruFocus. Robinhood Markets (NASDAQ:HOOD) launched its second venture fund, listing Robinhood Ventures Fund II (RVII) on the NYSE after pricing 8 million shares at $25 each. The company said the offering raised $225.5 million. Robinhood shares were up 3.94% …
Sharemaestro market context Trend signal active 52 weeks -19.5%Update: Market Chatter: Robinhood Plans to Accelerate Debuts for Publicly Traded Closed-end Funds
(Updates with company response in the last two paragraphs.)Robinhood Markets (HOOD) plans to accelerate the pace of debuts for its publicly traded closed-end funds after its first two attempts to make private firms more accessible to its retail customers, Bloomberg reported Silver Upgrade to …
Sharemaestro market context Trend signal active 52 weeks -19.5%Companhia Siderurgica Nacional S.A. Stock 12‑Month Price Target Raised to $1.54, Implies 78% Upside
The 12-month average price target for Companhia Siderurgica Nacional S.A. (CSNA3) stock has been raised from $1.53 to $1.54 by 11 analysts, with a potential upside of 78% based on the August 12 closing price. Despite the increased price target, the consensus rating for …
Sabesp: Q2 Earnings Snapshot
Sabesp (Companhia de Saneamento Basico do Estado de Sao Paulo) reported a second-quarter profit of $289.7 million, with earnings of 7 cents per share when adjusted for non-recurring gains. The waste management company achieved revenue of $1.3 billion during the same period. This data …
AQR group discloses 1.4M Lionheart Holdings shares in 13G/A filing (CUB)
AQR Capital Management, LLC, along with AQR Capital Management Holdings, LLC and AQR Arbitrage, LLC, has disclosed an amended beneficial ownership of 1,400,000 Class A ordinary shares in Lionheart Holdings (CUB), representing 6.51% of the outstanding class. The entities hold shared voting and dispositive …
Sands Capital group (NASDAQ: IKT) discloses 9.3% Inhibikase stake plus large warrants
Sands Capital Life Sciences Pulse Fund II, L.P., along with related entities, has reported a beneficial ownership of 9.3% in Inhibikase Therapeutics, Inc. This stake includes 13,018,965 shares of common stock and substantial warrants for an additional 15.5 million shares, although these warrants are …
SBS Stock 12‑Month Price Target Cut to $6.86, Implies 34% Upside
The average 12-month price target for Companhia de Saneamento Basico Do Estado De Sao Paulo - Sabesp (SBSP3) stock has been revised down from $6.91 to $6.86, according to 14 analysts. This new target implies a potential upside of approximately 34% from the August …
Companhia de Saneamento Básico do Estado de São Paulo - SABESP 2026 Q2 - Results - Earnings Call Presentation
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) released its Q2 2026 earnings call presentation. The company reported an EPS of $0.06, missing estimates by $0.02, while revenue of $1.97 billion (18.40% Y/Y) beat expectations by $747.58 million. The article …
Anheuser-Busch InBev stock trades below ADR highs as euro listing softens
Anheuser-Busch InBev (ABI) stock shows a mixed performance between its euro home-market listing and its New York ADR. On August 13, 2026, Brussels-traded shares slipped slightly, while the US-listed BUD ADR, despite a recent daily decline, reflects a higher dollar valuation and solid market …
Copel (ELPC) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Wed, Aug. 5, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer - Daniel Slaviero Chief Financial Officer - Felipe Gutterres Vice President of Regulatory Affairs - Andre Gomes General Manager - Dennis Mulica Full Conference Call …
Sharemaestro market context Trend signal ended 52 weeks +30.9%Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp (NYSE:SBS) Trading Down 6.8% Following Weak Earnings
Companhia de Saneamento Basico Do Estado De Sao Paulo - Sabesp (NYSE:SBS) experienced a 6.8% drop in its stock price after reporting weaker-than-expected quarterly earnings and revenue. The company missed analyst consensus estimates with earnings of $0.07 per share and revenue of $1.16 billion. …
Robinhood's co-founder wants to build AI data centers in space, not in people's backyards
Listen and subscribe to Power Players with Brian Sozzi on Apple Podcasts, Amazon Music, Spotify, YouTube, or wherever you find your favorite podcasts. The not-in-my-backyard, anti-AI data center crew has at least one prominent supporter: Robinhood (HOOD) co-founder and space racer Baiju Bhatt. Bhatt …
Sharemaestro market context Trend signal active 52 weeks -19.5%Robinhood's second venture fund debuts, drawing retail money into private markets
By Manya Saini Aug 13 (Reuters) - Robinhood's second venture fund debuted on Thursday, giving retail investors access to early-stage startups that have traditionally been out of reach for all but venture capital firms and wealthy investors. The fintech company raised $225.5 million in …
Sharemaestro market context Trend signal active 52 weeks -19.5%Copel Board Approves R$706 Million Interest on Equity and 2025 Form 20-F Filing
Copel's board of directors approved the distribution of R$706 million in interest on equity to shareholders, with payment scheduled for September 30, 2026. Concurrently, the board cleared the company's 2025 Form 20-F for filing with the U.S. SEC, enhancing transparency and regulatory compliance for …
Shinhan Financial (SHG) is on the Move, Here's Why the Trend Could be Sustainable
When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a trend to profit from it is easier said than done. …
SBS Stock Slides As Traders Reprice Defensive Utility Play
Companhia de saneamento Basico Do Estado De Sao Paulo – Sabesp (SBS) stock has fallen by 8.92% due to privatization uncertainty. The stock has dropped from the $5.80 area to the mid-$4s, breaking a multi-week uptrend. Despite solid earnings and reasonable valuation, the stock's …
Oppenheimer Maintains Inhibikase Therapeutics(IKT.US) With Buy Rating, Maintains Target Price $5
Oppenheimer has reiterated its Buy rating on Inhibikase Therapeutics (IKT.US), maintaining a target price of $5. This indicates continued confidence from the firm in the company's prospects.